tiprankstipranks
Trending News
More News >
BioCorRx Inc (BICX)
OTHER OTC:BICX
US Market

BioCorRx (BICX) Stock Statistics & Valuation Metrics

Compare
5 Followers

Total Valuation

BioCorRx has a market cap or net worth of $6.12M. The enterprise value is $8.63M.
Market Cap$6.12M
Enterprise Value$8.63M

Share Statistics

BioCorRx has 16,996,851 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,996,851
Owned by Insiders
Owned by Institutions

Financial Efficiency

BioCorRx’s return on equity (ROE) is 0.42 and return on invested capital (ROIC) is 96.92%.
Return on Equity (ROE)0.42
Return on Assets (ROA)-13.23
Return on Invested Capital (ROIC)96.92%
Return on Capital Employed (ROCE)0.65
Revenue Per Employee2.56K
Profits Per Employee-1.74M
Employee Count3
Asset Turnover0.02
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of BioCorRx is -0.78. BioCorRx’s PEG ratio is 0.05.
PE Ratio-0.78
PS Ratio0.00
PB Ratio-0.87
Price to Fair Value-0.33
Price to FCF-3.44
Price to Operating Cash Flow-3.44
PEG Ratio0.05

Income Statement

In the last 12 months, BioCorRx had revenue of 7.67K and earned -5.11M in profits. Earnings per share was -0.49.
Revenue7.67K
Gross Profit6.00K
Operating Income-5.12M
Pretax Income-5.21M
Net Income-5.11M
EBITDA-3.59M
Earnings Per Share (EPS)-0.49

Cash Flow

In the last 12 months, operating cash flow was -1.45M and capital expenditures 3.00, giving a free cash flow of -1.45M billion.
Operating Cash Flow-1.45M
Free Cash Flow-1.45M
Free Cash Flow per Share-0.09

Dividends & Yields

BioCorRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.40
52-Week Price Change-30.77%
50-Day Moving Average0.33
200-Day Moving Average0.36
Relative Strength Index (RSI)53.74
Average Volume (3m)1.11K

Important Dates

BioCorRx upcoming earnings date is May 20, 2025, TBA (Confirmed).
Last Earnings DateNov 12, 2024
Next Earnings DateMay 20, 2025
Ex-Dividend Date

Financial Position

BioCorRx as a current ratio of 0.01, with Debt / Equity ratio of -20.77%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap0.66
Net Debt to EBITDA-0.76
Interest Coverage Ratio-3.35

Taxes

In the past 12 months, BioCorRx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

BioCorRx EV to EBITDA ratio is -1.87, with an EV/FCF ratio of -6.11.
EV to Sales873.42
EV to EBITDA-1.87
EV to Free Cash Flow-6.11
EV to Operating Cash Flow-6.11

Balance Sheet

BioCorRx has $24.14K in cash and marketable securities with $2.74M in debt, giving a net cash position of $2.72M billion.
Cash & Marketable Securities$24.14K
Total Debt$2.74M
Net Cash$2.72M
Net Cash Per Share$0.16
Tangible Book Value Per Share-$1.18

Margins

Gross margin is 92.85%, with operating margin of -66829.81%, and net profit margin of -66616.10%.
Gross Margin92.85%
Operating Margin-66829.81%
Pretax Margin-67998.72%
Net Profit Margin-66616.10%
EBITDA Margin-46827.16%
EBIT Margin-48069.78%

Analyst Forecast

The average price target for BioCorRx is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-91.40%
EPS Growth Forecast-8.98%

Scores

Smart ScoreN/A
AI Score28
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis